ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

Lymphoma Foundation Offers Research Grants

June 28, 1996

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

ONCC Says 1,480 Nurses Passed Certification Exam

January 6, 1989

Clearinghouse Exec. Secty, Says It Has Failed in Its Objectives, Recommends It Be Dropped

January 13, 1978

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson In U.S. News & World Report Ranking

July 18, 2014